Chemoinformaics analysis of Quindoline Antimicrobial
| Molecular Weight | 218.259 | nRot | 0 |
| Heavy Atom Molecular Weight | 208.179 | nRig | 20 |
| Exact Molecular Weight | 218.084 | nRing | 4 |
| Solubility: LogS | -4.773 | nHRing | 2 |
| Solubility: LogP | 3.812 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 17 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 20 |
| nHA | 1 | APOL | 33.9179 |
| nHD | 1 | BPOL | 11.7421 |
| QED | 0.477 |
| Synth | 1.854 |
| Natural Product Likeliness | -0.241 |
| NR-PPAR-gamma | 0.954 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.051 |
| Pgp-sub | 0.056 |
| HIA | 0.006 |
| CACO-2 | -4.969 |
| MDCK | 0.0000162 |
| BBB | 0.755 |
| PPB | 0.973771 |
| VDSS | 1.154 |
| FU | 0.0150596 |
| CYP1A2-inh | 0.995 |
| CYP1A2-sub | 0.404 |
| CYP2c19-inh | 0.608 |
| CYP2c19-sub | 0.114 |
| CYP2c9-inh | 0.487 |
| CYP2c9-sub | 0.85 |
| CYP2d6-inh | 0.761 |
| CYP2d6-sub | 0.888 |
| CYP3a4-inh | 0.558 |
| CYP3a4-sub | 0.195 |
| CL | 3.885 |
| T12 | 0.331 |
| hERG | 0.068 |
| Ames | 0.875 |
| ROA | 0.181 |
| SkinSen | 0.918 |
| Carcinogencity | 0.815 |
| EI | 0.986 |
| Respiratory | 0.927 |
| NR-Aromatase | 0.743 |
| Antiviral | No |
| Prediction | 0.602631 |